Vyzkoušejte nový nástroj s podporou AI
Summon Research Assistant
BETA
奈良宣言(ALT over 30)のMASLD(metabolic dysfunction-associated steatotic liver disease)における臨床的意義の検証
則武, 秀尚, 新垣, 伸吾, 中島, 淳, 川中, 美和, 前城, 達次, 角田, 圭雄, 植田, 真一郎, 宗景, 玄祐, 兵庫, 秀幸, 鎌田, 佳宏, 正木, 勉, 相島, 慎一, 豊田, 秀徳, 飛田, 博史, 安田, 諭, 岩城, 慶大, 小野, 正文, 冨田, 栄一, 川口, 巧, 森下, 朝洋, 堤, 翼, 澤田, 康司, 高橋, 宏和, 荒木, 亜寿香, 岡上, 武, 林, 秀樹, 徳重, 明央, 吉田, 雄一, 内藤, 雅文, 藤井, 英樹, 大枝, 敏, 川田, 一仁, 米田, 正人, Japan Study Group of Nonalcoholic Fatty Liver Disease(JSG-NAFLD)
Published in 肝臓 (01.04.2024)
Published in 肝臓 (01.04.2024)
Get full text
Journal Article
Lifestyle changes during the coronavirus disease 2019 pandemic impact metabolic dysfunction–associated fatty liver disease
Fujii, Hideki, Nakamura, Naotoshi, Fukumoto, Shinya, Kimura, Tatsuo, Nakano, Akemi, Nadatani, Yuji, Tauchi, Yukie, Nishii, Yuuko, Takashima, Shingo, Kamada, Yoshihiro, Watanabe, Toshio, Kawada, Norifumi
Published in Liver international (01.05.2022)
Published in Liver international (01.05.2022)
Get full text
Journal Article